Evans DG, Kalamarides M, Hunter-Schaedle K, Blakeley J, Allen J, Babovic-Vuskanovic D, Belzberg A, Bollag G, Chen R, DiTomaso E, Golfinos J, Harris G, Jacob A, Kalpana G, Karajannis M, Korf B, Kurzrock R, Law M, McClatchey A, Packer R, Roehm P, Rubenstein A, Slattery W, Tonsgard JH, Welling DB, Widemann B, Yohay K, Giovannini M
Clinical cancer research : an official journal of the American Association for Cancer Research
Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2. Clin Cancer Res. 2009 Aug 15; 15(16):5032-5039.
Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2.
Benhamouche-Trouillet S, O'Loughlin E, Liu CH, Polacheck W, Fitamant J, McKee M, El-Bardeesy N, Chen CS, McClatchey AI
Proliferation-independent role of NF2 (merlin) in limiting biliary morphogenesis. Development. 2018 04 30; 145(9).
Proliferation-independent role of NF2 (merlin) in limiting biliary morphogenesis.
Blakeley JO, Evans DG, Adler J, Brackmann D, Chen R, Ferner RE, Hanemann CO, Harris G, Huson SM, Jacob A, Kalamarides M, Karajannis MA, Korf BR, Mautner VF, McClatchey AI, Miao H, Plotkin SR, Slattery W, Stemmer-Rachamimov AO, Welling DB, Wen PY, Widemann B, Hunter-Schaedle K, Giovannini M
American journal of medical genetics. Part A
Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2. Am J Med Genet A. 2012 Jan; 158A(1):24-41.
Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2.
Hebert AM, DuBoff B, Casaletto JB, Gladden AB, McClatchey AI
Merlin/ERM proteins establish cortical asymmetry and centrosome position. Genes Dev. 2012 Dec 15; 26(24):2709-23.
Merlin/ERM proteins establish cortical asymmetry and centrosome position.
Mouse models of neurofibromatosis. Biochim Biophys Acta. 2001; 1471(2):M73-80.
Wong HK, Lahdenranta J, Kamoun WS, Chan AW, McClatchey AI, Plotkin SR, Jain RK, di Tomaso E
Anti-vascular endothelial growth factor therapies as a novel therapeutic approach to treating neurofibromatosis-related tumors. Cancer Res. 2010 May 01; 70(9):3483-93.
Anti-vascular endothelial growth factor therapies as a novel therapeutic approach to treating neurofibromatosis-related tumors.
Pflugers Archiv : European journal of physiology
Modification of the Na+ current conducted by the rat skeletal muscle alpha subunit by coexpression with a human brain beta subunit. Pflugers Arch. 1993 Apr; 423(1-2):155-7.
Modification of the Na+ current conducted by the rat skeletal muscle alpha subunit by coexpression with a human brain beta subunit.
Organizing the cell cortex: the role of ERM proteins. Nat Rev Mol Cell Biol. 2010 Apr; 11(4):276-87.
Organizing the cell cortex: the role of ERM proteins.
SPRED proteins provide a NF-ty link to Ras suppression. Genes Dev. 2012 Jul 15; 26(14):1515-9.
SPRED proteins provide a NF-ty link to Ras suppression.
Lowe SW, Bodis S, Bardeesy N, McClatchey A, Remington L, Ruley HE, Fisher DE, Jacks T, Pelletier J, Housman DE
Cold Spring Harbor symposia on quantitative biology
Apoptosis and the prognostic significance of p53 mutation. Cold Spring Harb Symp Quant Biol. 1994; 59:419-26.
Apoptosis and the prognostic significance of p53 mutation.
Chiasson-MacKenzie C, Morris ZS, Liu CH, Bradford WB, Koorman T, McClatchey AI
Merlin/ERM proteins regulate growth factor-induced macropinocytosis and receptor recycling by organizing the plasma membrane:cytoskeleton interface. Genes Dev. 2018 09 01; 32(17-18):1201-1214.
Merlin/ERM proteins regulate growth factor-induced macropinocytosis and receptor recycling by organizing the plasma membrane:cytoskeleton interface.
Tanzi RE, McClatchey AI, Lamperti ED, Villa-Komaroff L, Gusella JF, Neve RL
Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature. 1988 Feb 11; 331(6156):528-30.
Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease.
Contact inhibition (of proliferation) redux. Curr Opin Cell Biol. 2012 Oct; 24(5):685-94.
Contact inhibition (of proliferation) redux.
ERM proteins. Curr Biol. 2012 Sep 25; 22(18):R784-5.
Ramesh V, McClatchey AI, Ramesh N, Benoit LA, Berson EL, Shih VE, Gusella JF
Proceedings of the National Academy of Sciences of the United States of America
Molecular basis of ornithine aminotransferase deficiency in B-6-responsive and -nonresponsive forms of gyrate atrophy. Proc Natl Acad Sci U S A. 1988 Jun; 85(11):3777-80.
Molecular basis of ornithine aminotransferase deficiency in B-6-responsive and -nonresponsive forms of gyrate atrophy.
Allitto BA, Horn GT, Altherr MR, Richards B, McClatchey AI, Wasmuth JJ, Gusella JF
Detection by PCR of the VNTR polymorphism at D4S95. Nucleic Acids Res. 1991 Jul 25; 19(14):4015.
Detection by PCR of the VNTR polymorphism at D4S95.
Ezrin...a metastatic detERMinant? Cancer Cell. 2004 Feb; 5(2):113-4.
Gladden AB, Hebert AM, Schneeberger EE, McClatchey AI
The NF2 tumor suppressor, Merlin, regulates epidermal development through the establishment of a junctional polarity complex. Dev Cell. 2010 Nov 16; 19(5):727-39.
The NF2 tumor suppressor, Merlin, regulates epidermal development through the establishment of a junctional polarity complex.
Actin' Up to Stop SNFin Out TEAD. Dev Cell. 2018 12 17; 47(6):693-695.
Lim DJ, Rubenstein AE, Evans DG, Jacks T, Seizinger BG, Baser ME, Beebe D, Brackmann DE, Chiocca EA, Fehon RG, Giovannini M, Glazer R, Gusella JF, Gutmann DH, Korf B, Lieberman F, Martuza R, McClatchey AI, Parry DM, Pulst SM, Ramesh V, Ramsey WJ, Ratner N, Rutkowski JL, Ruttledge M, Weinstein DE
Advances in neurofibromatosis 2 (NF2): a workshop report. J Neurogenet. 2000 Jun; 14(2):63-106.
Advances in neurofibromatosis 2 (NF2): a workshop report.
Yajnik V, Paulding C, Sordella R, McClatchey AI, Saito M, Wahrer DC, Reynolds P, Bell DW, Lake R, van den Heuvel S, Settleman J, Haber DA
DOCK4, a GTPase activator, is disrupted during tumorigenesis. Cell. 2003 Mar 07; 112(5):673-84.
DOCK4, a GTPase activator, is disrupted during tumorigenesis.
Johannessen CM, Johnson BW, Williams SM, Chan AW, Reczek EE, Lynch RC, Rioth MJ, McClatchey A, Ryeom S, Cichowski K
TORC1 is essential for NF1-associated malignancies. Curr Biol. 2008 Jan 08; 18(1):56-62.
TORC1 is essential for NF1-associated malignancies.
Hasib Sabbagh Professor of Systems Biology
Giovanni Armenise - Harvard Professor of Neurology
James Stillman Professor of Developmental Biology
Bullard Professor of Neurogenetics in the Department of Genetics
Kutys ML, Polacheck WJ, Welch MK, Gagnon KA, Koorman T, Kim S, Li L, McClatchey AI, Chen CS
Uncovering mutation-specific morphogenic phenotypes and paracrine-mediated vessel dysfunction in a biomimetic vascularized mammary duct platform. Nat Commun. 2020 07 06; 11(1):3377.
Uncovering mutation-specific morphogenic phenotypes and paracrine-mediated vessel dysfunction in a biomimetic vascularized mammary duct platform.
Inside-out construction of the biliary system
EPHecting cell contact by increasing cortical tension. J Cell Biol. 2021 06 07; 220(6).
EPHecting cell contact by increasing cortical tension.
Chiasson-MacKenzie C, Vitte J, Liu CH, Wright EA, Flynn EA, Stott SL, Giovannini M, McClatchey AI
Cellular mechanisms of heterogeneity in NF2-mutant schwannoma. Nat Commun. 2023 03 21; 14(1):1559.
Cellular mechanisms of heterogeneity in NF2-mutant schwannoma.
Chiasson-MacKenzie C, Zhang Y, O'Loughlin E, Dave PS, Menon AS, Westerfield AD, Kumar V, Bhatia SN, Rheinbay E, Bardeesy N, Stott SL, McClatchey AI
bioRxiv : the preprint server for biology
Distinct phenotypic consequences of cholangiocarcinoma-associated FGFR2 alterations depend on biliary epithelial cell state. bioRxiv. 2025 Sep 15.
Distinct phenotypic consequences of cholangiocarcinoma-associated FGFR2 alterations depend on biliary epithelial cell state.
Pore D, Parameswaran N, Matsui K, Stone MB, Saotome I, McClatchey AI, Veatch SL, Gupta N
Journal of immunology (Baltimore, Md. : 1950)
Ezrin tunes the magnitude of humoral immunity. J Immunol. 2013 Oct 15; 191(8):4048-58.
Ezrin tunes the magnitude of humoral immunity.
Widemann BC, Acosta MT, Ammoun S, Belzberg AJ, Bernards A, Blakeley J, Bretscher A, Cichowski K, Clapp DW, Dombi E, Evans GD, Ferner R, Fernandez-Valle C, Fisher MJ, Giovannini M, Gutmann DH, Hanemann CO, Hennigan R, Huson S, Ingram D, Kissil J, Korf BR, Legius E, Packer RJ, McClatchey AI, McCormick F, North K, Pehrsson M, Plotkin SR, Ramesh V, Ratner N, Schirmer S, Sherman L, Schorry E, Stevenson D, Stewart DR, Ullrich N, Bakker AC, Morrison H
CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies. Am J Med Genet A. 2014 Mar; 164A(3):563-78.
CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies.
Shapiro IM, Kolev VN, Vidal CM, Kadariya Y, Ring JE, Wright Q, Weaver DT, Menges C, Padval M, McClatchey AI, Xu Q, Testa JR, Pachter JA
Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship. Sci Transl Med. 2014 May 21; 6(237):237ra68.
Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship.
ERM proteins at a glance. J Cell Sci. 2014 Aug 01; 127(Pt 15):3199-204.
Plotkin SR, Albers AC, Babovic-Vuksanovic D, Blakeley JO, Breakefield XO, Dunn CM, Evans DG, Fisher MJ, Friedman JM, Giovannini M, Gutmann DH, Kalamarides M, McClatchey AI, Messiaen L, Morrison H, Parkinson DB, Stemmer-Rachamimov AO, Van Raamsdonk CD, Riccardi VM, Rosser T, Schindeler A, Smith MJ, Stevenson DA, Ullrich NJ, van der Vaart T, Weiss B, Widemann BC, Zhu Y, Bakker AC, Lloyd AC
Update from the 2013 International Neurofibromatosis Conference. Am J Med Genet A. 2014 Dec; 164A(12):2969-78.
Update from the 2013 International Neurofibromatosis Conference.
Chiasson-MacKenzie C, Morris ZS, Baca Q, Morris B, Coker JK, Mirchev R, Jensen AE, Carey T, Stott SL, Golan DE, McClatchey AI
NF2/Merlin mediates contact-dependent inhibition of EGFR mobility and internalization via cortical actomyosin. J Cell Biol. 2015 Oct 26; 211(2):391-405.
NF2/Merlin mediates contact-dependent inhibition of EGFR mobility and internalization via cortical actomyosin.
Functional analysis of ERM proteins in epithelial morphogenesis
Molecular Function of the Nf2 Tumor Suppressor, Merlin
Modeling metastasis in the mouse. Oncogene. 1999 Sep 20; 18(38):5334-9.
Stemmer-Rachamimov AO, Louis DN, Nielsen GP, Antonescu CR, Borowsky AD, Bronson RT, Burns DK, Cervera P, McLaughlin ME, Reifenberger G, Schmale MC, MacCollin M, Chao RC, Cichowski K, Kalamarides M, Messerli SM, McClatchey AI, Niwa-Kawakita M, Ratner N, Reilly KM, Zhu Y, Giovannini M
Comparative pathology of nerve sheath tumors in mouse models and humans. Cancer Res. 2004 May 15; 64(10):3718-24.
Comparative pathology of nerve sheath tumors in mouse models and humans.
McClatchey AI, McKenna-Yasek D, Cros D, Worthen HG, Kuncl RW, DeSilva SM, Cornblath DR, Gusella JF, Brown RH
Novel mutations in families with unusual and variable disorders of the skeletal muscle sodium channel. Nat Genet. 1992 Oct; 2(2):148-52.
Novel mutations in families with unusual and variable disorders of the skeletal muscle sodium channel.
Neurofibromatosis type II: mouse models reveal broad roles in tumorigenesis and metastasis. Mol Med Today. 2000 Jun; 6(6):252-3.
Neurofibromatosis type II: mouse models reveal broad roles in tumorigenesis and metastasis.
Lallemand D, Curto M, Saotome I, Giovannini M, McClatchey AI
NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions. Genes Dev. 2003 May 01; 17(9):1090-100.
NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions.
Fitamant J, Kottakis F, Benhamouche S, Tian HS, Chuvin N, Parachoniak CA, Nagle JM, Perera RM, Lapouge M, Deshpande V, Zhu AX, Lai A, Min B, Hoshida Y, Avruch J, Sia D, Campreciós G, McClatchey AI, Llovet JM, Morrissey D, Raj L, Bardeesy N
YAP Inhibition Restores Hepatocyte Differentiation in Advanced HCC, Leading to Tumor Regression. Cell Rep. 2015 Mar 17; 10(10):1692-1707.
YAP Inhibition Restores Hepatocyte Differentiation in Advanced HCC, Leading to Tumor Regression.
Gusella JF, Altherr MR, McClatchey AI, Doucette-Stamm LA, Tagle D, Plummer S, Groot N, Barnes G, Hummerich H, Collins FS
Sequence-tagged sites (STSs) spanning 4p16.3 and the Huntington disease candidate region. Genomics. 1992 May; 13(1):75-80.
Sequence-tagged sites (STSs) spanning 4p16.3 and the Huntington disease candidate region.
Altomare DA, Vaslet CA, Skele KL, De Rienzo A, Devarajan K, Jhanwar SC, McClatchey AI, Kane AB, Testa JR
A mouse model recapitulating molecular features of human mesothelioma. Cancer Res. 2005 Sep 15; 65(18):8090-5.
A mouse model recapitulating molecular features of human mesothelioma.
Bonilha VL, Rayborn ME, Saotome I, McClatchey AI, Hollyfield JG
Microvilli defects in retinas of ezrin knockout mice. Exp Eye Res. 2006 Apr; 82(4):720-9.
Microvilli defects in retinas of ezrin knockout mice.
McClatchey AI, Trofatter J, McKenna-Yasek D, Raskind W, Bird T, Pericak-Vance M, Gilchrist J, Arahata K, Radosavljevic D, Worthen HG
Dinucleotide repeat polymorphisms at the SCN4A locus suggest allelic heterogeneity of hyperkalemic periodic paralysis and paramyotonia congenita. Am J Hum Genet. 1992 May; 50(5):896-901.
Dinucleotide repeat polymorphisms at the SCN4A locus suggest allelic heterogeneity of hyperkalemic periodic paralysis and paramyotonia congenita.
McClatchey AI, Saotome I, Mercer K, Crowley D, Gusella JF, Bronson RT, Jacks T
Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes Dev. 1998 Apr 15; 12(8):1121-33.
Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors.
Spatial regulation of receptor tyrosine kinases in development and cancer. Nat Rev Cancer. 2012 May 24; 12(6):387-400.
Spatial regulation of receptor tyrosine kinases in development and cancer.
Horn GT, McClatchey AI, Richards B, MacDonald ME, Gusella JF
Detection by PCR of a VNTR polymorphism at D4S43. Nucleic Acids Res. 1991 Sep 11; 19(17):4772.
Detection by PCR of a VNTR polymorphism at D4S43.
Weiss WA, Israel M, Cobbs C, Holland E, James CD, Louis DN, Marks C, McClatchey AI, Roberts T, Van Dyke T, Wetmore C, Chiu IM, Giovannini M, Guha A, Higgins RJ, Marino S, Radovanovic I, Reilly K, Aldape K
Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum. Oncogene. 2002 Oct 24; 21(49):7453-63.
Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum.
Merlin and ERM proteins: unappreciated roles in cancer development? Nat Rev Cancer. 2003 11; 3(11):877-83.
Merlin and ERM proteins: unappreciated roles in cancer development?
McClatchey AI, Lin CS, Wang J, Hoffman EP, Rojas C, Gusella JF
The genomic structure of the human skeletal muscle sodium channel gene. Hum Mol Genet. 1992 Oct; 1(7):521-7.
The genomic structure of the human skeletal muscle sodium channel gene.
Bruce B, Khanna G, Ren L, Landberg G, Jirström K, Powell C, Borczuk A, Keller ET, Wojno KJ, Meltzer P, Baird K, McClatchey A, Bretscher A, Hewitt SM, Khanna C
Expression of the cytoskeleton linker protein ezrin in human cancers. Clin Exp Metastasis. 2007; 24(2):69-78.
Expression of the cytoskeleton linker protein ezrin in human cancers.
Kaufman DL, Ramesh V, McClatchey AI, Menkes JH, Tobin AJ
Detection of point mutations associated with genetic diseases by an exon scanning technique. Genomics. 1990 Dec; 8(4):656-63.
Detection of point mutations associated with genetic diseases by an exon scanning technique.
Regulation of the neurofibromatosis type 2 tumor suppressor protein, merlin, by adhesion and growth arrest stimuli. J Biol Chem. 1998 Mar 27; 273(13):7757-64.
Regulation of the neurofibromatosis type 2 tumor suppressor protein, merlin, by adhesion and growth arrest stimuli.
Current opinion in genetics & development
Tumor suppressor mutations in mice: the next generation. Curr Opin Genet Dev. 1998 Jun; 8(3):304-10.
Tumor suppressor mutations in mice: the next generation.
Neurofibromatosis. Annu Rev Pathol. 2007; 2:191-216.
Kim WJ, Okimoto RA, Purton LE, Goodwin M, Haserlat SM, Dayyani F, Sweetser DA, McClatchey AI, Bernard OA, Look AT, Bell DW, Scadden DT, Haber DA
Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemias. Blood. 2008 May 01; 111(9):4716-22.
Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemias.
Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T
p53 status and the efficacy of cancer therapy in vivo. Science. 1994 Nov 04; 266(5186):807-10.
p53 status and the efficacy of cancer therapy in vivo.
McClatchey AI, Saotome I, Ramesh V, Gusella JF, Jacks T
The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation. Genes Dev. 1997 May 15; 11(10):1253-65.
The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research
Localization and functional domains of the neurofibromatosis type II tumor suppressor, merlin. Cell Growth Differ. 1998 Apr; 9(4):287-96.
Localization and functional domains of the neurofibromatosis type II tumor suppressor, merlin.
Nf2/Merlin: a coordinator of receptor signalling and intercellular contact. Br J Cancer. 2008 Jan 29; 98(2):256-62.
Nf2/Merlin: a coordinator of receptor signalling and intercellular contact.
Aberrant epithelial morphology and persistent epidermal growth factor receptor signaling in a mouse model of renal carcinoma. Proc Natl Acad Sci U S A. 2009 Jun 16; 106(24):9767-72.
Aberrant epithelial morphology and persistent epidermal growth factor receptor signaling in a mouse model of renal carcinoma.
Heiska L, Melikova M, Zhao F, Saotome I, McClatchey AI, Carpén O
Ezrin is key regulator of Src-induced malignant phenotype in three-dimensional environment. Oncogene. 2011 Dec 15; 30(50):4953-62.
Ezrin is key regulator of Src-induced malignant phenotype in three-dimensional environment.
Cold Spring Harbor perspectives in biology
Cell-Cell Contact and Receptor Tyrosine Kinase Signaling. Cold Spring Harb Perspect Biol. 2018 06 01; 10(6).
Cell-Cell Contact and Receptor Tyrosine Kinase Signaling.
2017 Cell Contact and Adhesion Gordon Research Conference and Gordon Research Seminar
Casaletto JB, Saotome I, Curto M, McClatchey AI
Ezrin-mediated apical integrity is required for intestinal homeostasis. Proc Natl Acad Sci U S A. 2011 Jul 19; 108(29):11924-9.
Ezrin-mediated apical integrity is required for intestinal homeostasis.
Youngman S, Bates GP, Williams S, McClatchey AI, Baxendale S, Sedlacek Z, Altherr M, Wasmuth JJ, MacDonald ME, Gusella JF
The telomeric 60 kb of chromosome arm 4p is homologous to telomeric regions on 13p, 15p, 21p, and 22p. Genomics. 1992 Oct; 14(2):350-6.
The telomeric 60 kb of chromosome arm 4p is homologous to telomeric regions on 13p, 15p, 21p, and 22p.
Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin. Genes Dev. 2005 Oct 01; 19(19):2265-77.
Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin.
Shaffer MH, Dupree RS, Zhu P, Saotome I, Schmidt RF, McClatchey AI, Freedman BD, Burkhardt JK
Ezrin and moesin function together to promote T cell activation. J Immunol. 2009 Jan 15; 182(2):1021-32.
Ezrin and moesin function together to promote T cell activation.
Benhamouche S, Curto M, Saotome I, Gladden AB, Liu CH, Giovannini M, McClatchey AI
Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver. Genes Dev. 2010 Aug 15; 24(16):1718-30.
Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver.
Ezrin is essential for epithelial organization and villus morphogenesis in the developing intestine. Dev Cell. 2004 Jun; 6(6):855-64.
Ezrin is essential for epithelial organization and villus morphogenesis in the developing intestine.
Plotkin SR, Singh MA, O'Donnell CC, Harris GJ, McClatchey AI, Halpin C
Audiologic and radiographic response of NF2-related vestibular schwannoma to erlotinib therapy. Nat Clin Pract Oncol. 2008 Aug; 5(8):487-91.
Audiologic and radiographic response of NF2-related vestibular schwannoma to erlotinib therapy.
Larsson J, Ohishi M, Garrison B, Aspling M, Janzen V, Adams GB, Curto M, McClatchey AI, Schipani E, Scadden DT
Nf2/merlin regulates hematopoietic stem cell behavior by altering microenvironmental architecture. Cell Stem Cell. 2008 Aug 07; 3(2):221-7.
Nf2/merlin regulates hematopoietic stem cell behavior by altering microenvironmental architecture.
Curto M, Cole BK, Lallemand D, Liu CH, McClatchey AI
Contact-dependent inhibition of EGFR signaling by Nf2/Merlin. J Cell Biol. 2007 Jun 04; 177(5):893-903.
Contact-dependent inhibition of EGFR signaling by Nf2/Merlin.
McClatchey AI, Kaufman DL, Berson EL, Tobin AJ, Shih VE, Gusella JF, Ramesh V
Splicing defect at the ornithine aminotransferase (OAT) locus in gyrate atrophy. Am J Hum Genet. 1990 Nov; 47(5):790-4.
Splicing defect at the ornithine aminotransferase (OAT) locus in gyrate atrophy.
Merlin and the ERM proteins--regulators of receptor distribution and signaling at the cell cortex. Trends Cell Biol. 2009 May; 19(5):198-206.
Merlin and the ERM proteins--regulators of receptor distribution and signaling at the cell cortex.
Cole BK, Curto M, Chan AW, McClatchey AI
Localization to the cortical cytoskeleton is necessary for Nf2/merlin-dependent epidermal growth factor receptor silencing. Mol Cell Biol. 2008 Feb; 28(4):1274-84.
Localization to the cortical cytoskeleton is necessary for Nf2/merlin-dependent epidermal growth factor receptor silencing.
The neurofibroma cell of origin: SKPs expand the playing field. Cell Stem Cell. 2009 May 08; 4(5):371-2.
The neurofibroma cell of origin: SKPs expand the playing field.
Tanzi RE, St George-Hyslop PH, Haines JL, Polinsky RJ, Nee L, Foncin JF, Neve RL, McClatchey AI, Conneally PM, Gusella JF
The genetic defect in familial Alzheimer's disease is not tightly linked to the amyloid beta-protein gene. Nature. 1987 Sep 10-16; 329(6135):156-7.
The genetic defect in familial Alzheimer's disease is not tightly linked to the amyloid beta-protein gene.
McClatchey AI, Cannon SC, Slaugenhaupt SA, Gusella JF
The cloning and expression of a sodium channel beta 1-subunit cDNA from human brain. Hum Mol Genet. 1993 Jun; 2(6):745-9.
The cloning and expression of a sodium channel beta 1-subunit cDNA from human brain.
Shaffer MH, Huang Y, Corbo E, Wu GF, Velez M, Choi JK, Saotome I, Cannon JL, McClatchey AI, Sperling AI, Maltzman JS, Oliver PM, Bhandoola A, Laufer TM, Burkhardt JK
Ezrin is highly expressed in early thymocytes, but dispensable for T cell development in mice. PLoS One. 2010 Aug 27; 5(8):e12404.
Ezrin is highly expressed in early thymocytes, but dispensable for T cell development in mice.
EGFR-induced cytoskeletal changes drive complex cell behaviors: The tip of the iceberg. Sci Signal. 2018 01 30; 11(515).
EGFR-induced cytoskeletal changes drive complex cell behaviors: The tip of the iceberg.
McClatchey AI, Van den Bergh P, Pericak-Vance MA, Raskind W, Verellen C, McKenna-Yasek D, Rao K, Haines JL, Bird T, Brown RH
Temperature-sensitive mutations in the III-IV cytoplasmic loop region of the skeletal muscle sodium channel gene in paramyotonia congenita. Cell. 1992 Feb 21; 68(4):769-74.
Temperature-sensitive mutations in the III-IV cytoplasmic loop region of the skeletal muscle sodium channel gene in paramyotonia congenita.
Allitto BA, McClatchey AI, Barnes G, Altherr M, Wasmuth J, Frischauf AM, MacDonald ME, Gusella J
Assay by polymerase chain reaction (PCR) of multi-allele polymorphisms in the Huntington's disease region of chromosome 4. Mol Cell Probes. 1992 Dec; 6(6):513-20.
Assay by polymerase chain reaction (PCR) of multi-allele polymorphisms in the Huntington's disease region of chromosome 4.
Shaw RJ, Paez JG, Curto M, Yaktine A, Pruitt WM, Saotome I, O'Bryan JP, Gupta V, Ratner N, Der CJ, Jacks T, McClatchey AI
The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling. Dev Cell. 2001 Jul; 1(1):63-72.
The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.